Canada · Who invested in Synucure Therapeutics?
Synucure Therapeutics's investors include Investissement Quebec.
Canada · Seed startup
Who invested in Synucure Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Synucure Therapeutics and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$2.8Mraised across 1 round since 2025, from 1 source
- Latest round
- Seed, $2.8MApr 2025
- Investors
- 1
The rounds
- Apr 2025
Founders and team
From Synucure Therapeutics's own website: 3 founders, 3 on the team.
Sylvain ChrétienPresident, Chief Executive Officer and Co-Founder
Dr. Francesca CicchettiChief Scientific Officer and Co-Founder
Louis-Régis TremblayCo-founder and Director ICD.D
- Dolorès CarballoSenior Project Manager
- Dr. Claude PichéChairman of the Board
- Norma BeauchampIndependent Director
AdvisersDr. Ben Cadieux
Quick answers about Synucure Therapeutics
How much has Synucure Therapeutics raised?
Synucure Therapeutics has raised $2.8M across 1 round since 2025.
When did Synucure Therapeutics last raise?
Synucure Therapeutics's most recent round was a Seed of $2.8M in Apr 2025.
What was Synucure Therapeutics's biggest round?
Its most recent round, $2.8M in Apr 2025, is also its largest on record.
Who backed Synucure Therapeutics first?
Synucure Therapeutics's first round on record, in Apr 2025, was backed by Investissement Quebec.
What stage is Synucure Therapeutics at?
Synucure Therapeutics's latest named round is a Seed, in Apr 2025.
Where is Synucure Therapeutics based?
Synucure Therapeutics is based in Canada.
Companies like Synucure Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.